{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:46:40Z","timestamp":1790084800562,"version":"4.0.1"},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T00:00:00Z","timestamp":1237420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2009,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neu2000 [NEU, 2\u2010hydroxy\u20105\u2010(2,3,5,6\u2010tetrafluoro\u20104\u2010trifluoromethyl\u2010benzylamino)\u2010benzoic acid], a derivative of sulfasalazine, attenuates NMDA\u2010induced neuronal toxicity. Here we investigated the effects of NEU on the NMDA receptor (NMDAR) using whole\u2010cell patch clamp technique to determine the molecular mechanisms underlying its neuroprotective role. NEU reversibly suppressed NMDA responses in an uncompetitive manner with fast binding kinetics. Its inhibition of NMDAR activity depended on both the concentration and the use of agonist but not on the membrane potential. NEU accelerated NMDA desensitization without affecting the binding affinity of NMDAR for its agonists and stabilized the closed state of NMDAR. Therefore, NEU should effectively alleviate disorders that are a result of glutamate excitoxicity with fewer side effects because it is a low\u2010affinity gating modifier that antagonizes NMDAR in an uncompetitive manner. Moreover, in the presence of ifenprodil (an NR2B antagonist) but not NVP\u2010AAM077 [(<jats:italic>R<\/jats:italic>)\u2010[(<jats:italic>S<\/jats:italic>)\u20101\u2010(4\u2010bromo\u2010phenyl)\u2010ethylamino]\u2010(2,3\u2010dioxo\u20101,2,3,4\u2010tetrahydro\u2010quinoxalin\u20105\u2010yl)\u2010methyl]\u2010phosphonic acid, an NR2A antagonist], the extent of NEU block was decreased, suggesting that NEU is an NR2B\u2010specific antagonist.<\/jats:p>","DOI":"10.1111\/j.1471-4159.2009.06044.x","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T11:08:26Z","timestamp":1237460906000},"page":"1261-1271","source":"Crossref","is-referenced-by-count":12,"title":["The novel NMDA receptor antagonist, 2\u2010hydroxy\u20105\u2010(2,3,5,6\u2010tetrafluoro\u20104\u2010trifluoromethyl\u2010benzylamino)\u2010benzoic acid, is a gating modifier in cultured mouse cortical neurons"],"prefix":"10.1111","volume":"109","author":[{"given":"Jihyun","family":"Noh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun\u2010sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun\u2010mo","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,5,12]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(02)00074-4"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6984"},{"key":"e_1_2_7_4_1","first-page":"251","article-title":"Renaissance of amantadine in the treatment of Parkinson\u2019s disease","volume":"91","author":"Blanchet P. J.","year":"2003","journal-title":"Adv. Neurol."},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4262-04.2005"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612054865082"},{"key":"e_1_2_7_8_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0031-6997(24)01394-2","article-title":"The glutamate receptor ion channels","volume":"51","author":"Dingledine R.","year":"1999","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1995.1018"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2007.05.022"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jcbfm.9600418"},{"key":"e_1_2_7_12_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nn835","article-title":"Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut\u2010off and cell death pathways","volume":"5","author":"Hardingham G. E.","year":"2002","journal-title":"Nat. Neurosci."},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2007.137679"},{"key":"e_1_2_7_14_1","first-page":"505","volume-title":"Ion Channels of Excitable Membranes","author":"Hille B.","year":"2001"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(02)00164-3"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn936"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021807"},{"key":"e_1_2_7_18_1","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0026-895X(25)09630-0","article-title":"Calcium\u2010dependent inactivation of recombinant N\u2010methyl\u2010d\u2010aspartate receptors is NR2 subunit specific","volume":"50","author":"Krupp J. J.","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_19_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0026-895X(25)12936-2","article-title":"Ifenprodil blocks N\u2010methyl\u2010d\u2010aspartate receptors by a two\u2010component mechanism","volume":"40","author":"Legendre P.","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.13-02-00674.1993"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nn912"},{"issue":"6","key":"e_1_2_7_22_1","first-page":"S61","article-title":"Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer\u2019s disease and other neurologic disorders","volume":"6","author":"Lipton S. A.","year":"2004","journal-title":"J. Alzheimers. Dis."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2476-04.2004"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0116-07.2007"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroscience.2008.01.080"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/338425a0"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1999.tb07979.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2007.147652"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s000180050199"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2005.12.002"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2005.07.020"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199704000-00021"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0028-3908(95)00092-K"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.51"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200666110-00015"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190202"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.042606"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(90)90198-O"},{"key":"e_1_2_7_39_1","doi-asserted-by":"crossref","first-page":"10611","DOI":"10.1523\/JNEUROSCI.19-24-10611.1999","article-title":"Probing of NMDA channels with fast blockers","volume":"19","author":"Sobolevsky A. I.","year":"1999","journal-title":"J. Neurosci."},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.00771.2005"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1994.72.2.754"},{"key":"e_1_2_7_42_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0026-895X(25)13275-6","article-title":"Ifenprodil discriminates subtypes of the N\u2010methyl\u2010d\u2010aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors","volume":"44","author":"Williams K.","year":"1993","journal-title":"Mol. Pharmacol."}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-4159.2009.06044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-4159.2009.06044.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T15:21:25Z","timestamp":1739028085000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-4159.2009.06044.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,12]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1111\/j.1471-4159.2009.06044.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06044.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,12]]}}}